Arch Capital Group Ltd.
$87.14B- Market cap
- $33.47B
- Debt
- +$54.66B
- Cash
- −$993.00M
Capital structure 38% equity / 62% debt · EV / Revenue 4.37x · EV / EBITDA 15.49x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: ACGL stock price at discount vs DOCS $98.10 current versus $311.90 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DOCS's multiple
Implied fair value · at ACGL's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ACGL FY 2025 (ended Dec 31, 2025) · DOCS FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 38% equity / 62% debt · EV / Revenue 4.37x · EV / EBITDA 15.49x
Capital structure 99% equity / 1% debt · EV / Revenue 7.08x · EV / EBITDA 16.68x
ACGL carries the larger enterprise value at $87.14B against $4.56B; ACGL trades on the lower EV / Revenue multiple (4.37x vs 7.08x); ACGL on the lower EV / EBITDA (15.49x vs 16.68x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ARCH CAPITAL GROUP LTD. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Doximity, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.26x
0.05x
Net debt / EBITDA
Leverage against operating earnings
9.54x
-0.64x
Cash and equivalents
Liquid reserves on the balance sheet
$993.00M
$219.18M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Chubb Ltd
ACGL vs CB
TRAVELERS COMPANIES, INC.
ACGL vs TRV
BERKLEY W R CORP
ACGL vs WRB
RENAISSANCERE HOLDINGS LTD
ACGL vs RNR
CNA FINANCIAL CORP
ACGL vs CNA
HEALTHEQUITY, INC.
ACGL vs HQY
Teladoc Health, Inc.
ACGL vs TDOC
Hims & Hers Health, Inc.
ACGL vs HIMS
GoodRx Holdings, Inc.
ACGL vs GDRX
$54.66B
$44.32M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.